Log in to save to my catalogue

The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune recons...

The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune recons...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04016411v1

The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review

About this item

Full title

The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical microbiology & infectious diseases, 2023-04, Vol.42 (4), p.413-422

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Paradoxical reaction (PR) and immune reconstitution inflammatory syndrome (IRIS) are common complications of tuberculosis treatment. Corticosteroids are first-line treatment for severe PR or IRIS, particularly neurological. We report four cases of severe PR or IRIS during tuberculosis treatment who required TNF-α antagonists, and identified 20 addi...

Alternative Titles

Full title

The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04016411v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04016411v1

Other Identifiers

ISSN

0934-9723

E-ISSN

1435-4373

DOI

10.1007/s10096-023-04564-2

How to access this item